Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.110
-0.090 (-4.09%)
Dec 12, 2025, 10:40 AM EST - Market open
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $314.4 million as of December 12, 2025. Its market cap has increased by 9,753.11% in one year.
Market Cap
314.40M
Enterprise Value
322.79M
1-Year Change
9,753.11%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $314.40M, an increase of 318.81%. That is a compound annual growth rate of 36.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 327.81M | 7,082.66% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | 75.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |